CNS Pharmaceuticals to Present at Benzinga’s Virtual Biotech Conference
Live moderated webcast fireside chat on August 3rd at 11:35 AM ETHOUSTON, TX / ACCESSWIRE / August 3, 2023 /...
Year: 2023
CNS Pharmaceuticals Provides Clinical Trial Update for Ongoing Potentially Pivotal Study with Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
Company continued to see rapid progression and acceleration of enrollment with 180 patients enrolled to date across 46 clinical trial...
Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
BOULDER, CO / ACCESSWIRE / August 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
Bausch Health Announces Second-Quarter 2023 Results, Other Key Updates From the Quarter, and Raises Full-Year 2023 Revenue Outlook
Favorable Motion Ruling in Xifaxan® Litigation Reinforces Continuing Salix Growth StrategyBalance Sheet Initiatives Further Enhance Liquidity ProfileContinued Evaluation of Optimal...
Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
Second quarter 2023 revenues of $0.3 billion; net loss of $1.4 billion and loss per share of $3.62Company expecting 2023...
Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors
Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed...
Elevar Therapeutics to Host August 10 Virtual KOL Event on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)
FORT LEE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and...
Smart For Life to Present at the H.C. Wainwright 25th Annual Global Investment Conference
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a...
Precipio’s Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven
These efficiencies plus revenue growth expected to continue the positive momentumNEW HAVEN, Conn., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Specialty...
The Trip Report by Beckley Waves Launches The Trip Report Podcast
LONDON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The Trip Report by Beckley Waves, a leading publication on the business, science,...
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
- First of its kind, non-surgical, permanent birth control option begins enrollment in landmark trial -ATLANTA, Aug. 03, 2023 (GLOBE...
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently...
Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
MIAMI, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
IMUNON to Hold Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 10, 2023
LAWRENCEVILLE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated...
Nexalin’s CEO Mark White to be Interviewed Live on “The Big Biz Show” Today at 3PM Eastern Time
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced that...
Avricore’s HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom
VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”)...
Assure Holdings Acquires Certain Assets of Innovation Neuromonitoring, LLC
Expects to Increase Annual Number of Cases by More than 3,000DENVER, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Assure Holdings Corp....
GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conference
- Live moderated webcast fireside chat today, August 3rdat 11:15 AM ET LA JOLLA, CA, Aug. 03, 2023 (GLOBE NEWSWIRE)...
TOMI and Cellares to Collaborate on the Integration of SteraMist iHP Technology into Revolutionary New Cell Therapy Manufacturing Solution
FREDERICK, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (Nasdaq:BPTH) (“Bio-Path” or the “Company”), a biotechnology company leveraging its...